Clinical Trials Browser

Astrocytoma, Glioblastoma, Glioma

Astrocytoma, Lymphoma, Follicular

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

Glioblastoma

Neuroblastoma, Ganglioneuroblastoma

Medulloblastoma

Glioblastoma, Glioma

Glioblastoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Medulloblastoma

Brain Neoplasms, Breast Neoplasms, Glioblastoma, Melanoma, Prostatic Neoplasms

Glioblastoma

Glioblastoma

Neuroblastoma, Ganglioneuroblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Astrocytoma, Glioblastoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Ganglioneuroblastoma

Brain Neoplasms, Glioblastoma

Glioblastoma, Gliosarcoma

Glioblastoma, Recurrence

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Brain Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Brain Neoplasms, Meningeal Carcinomatosis

Glioblastoma

Medulloblastoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

Brain Neoplasms

Glioblastoma

Glioblastoma, Gliosarcoma

Diffuse Intrinsic Pontine Glioma

Clinical Trials

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma

PNOC023

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

GBM AGILE

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)

NausiCAA

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases

Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma